#til one if the first #ketamine studies for #mentalhealth was in 1973 out of #iran “The Use of Ketamine in Psychiatry” by
E. Khorramzadeh M.D, A.O. Lotfy M.D.
Assistant Professor, Dept. of Psychiatry, Pahlavi University School of Medicine, Shiraz, Iran
Professor, Dept. of Anesthesiology, Pahlavi University School of Medicine, Shiraz, Iran #psychedelics #ketaminetherapy #psychedelicresearch #nowar
https://www.sciencedirect.com/science/article/pii/S0033318273713062?via%3Dihub
The article argues that ideological concerns and media sensationalism, rather than scientific evidence of harm, shaped the global prohibition of psychedelics in 1971, with diplomacy and political context playing central roles.
The piece highlights how political and cultural factors influence perceptions of psychology-related substances, making it of particular interest to those studying how societal narratives shape mental health policy and research access.
Article Title: New analysis shows ideology, not science, drove the global prohibition of psychedelics
Link to PsyPost Article: https://www.psypost dot org/new-analysis-shows-ideology-not-science-drove-the-global-prohibition-of-psychedelics/
Copy and paste broken link above into your browser and replace "dot" with "." for link to work. We have to do it this way to avoid displaying copyrighted images.
#psychedelics #drugpolicy #UN #psychedelicresearch #historicalanalysis
"Findings indicate that individual psilocybin-assisted therapy has the potential for beneficial effects on mood and personality characteristics. Moreover, the study highlights the importance of subjective experiences and demographic factors in moderating this effect."
"Based on the currently available comparative evidence, which is almost entirely observational, IV ketamine and IN esketamine show comparable acute response and remission rates, though IV ketamine may act faster."
"Personality traits relate to baseline mental health severity but not short-term response to ketamine. Trauma history may predict greater benefit from treatment."
"results suggest that long-term Ayahuasca use may be linked to lasting changes in emotional regulation and brain function, potentially supporting psychological well-being."
"Findings suggested that racemic ketamine (including by mouth), when appropriately dosed and administered within a structured clinical and safety monitoring framework, is both effective, safe and well-tolerated over a 6-month treatment period."
Psychedelic Institute Project
Psychotherapy Commission ACPE
MO.Hash